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1.  INTRODUCTION 
 
According to the World Health Organization, cancer is the second leading cause 
of death in developed countries and is among the three leading causes of death for adults 
in developing countries (WHO). A steadily increasing proportion of elderly people in the 
world will result in approximately 16 million new cases of cancer by the year 2020 
(IARC).
[1] 
 
Due to environmental conditions and risk factors such as age, smoking, 
alcoholism, obesity, poor diet, lack of exercise, prolonged exposure to sunlight (UV 
Radiations) there is risk of developing cancer in every individual.
[2] 
 
Cervical cancer is the 3
rd
 most common cancer in women worldwide and the 
most common cancer causing death in developing countries.
[3]
 Sexually transmitted HPV 
infection is the most important risk factor for cervical intraepithelial neoplasm and 
invasive cervical cancer. 
 
In India with a population of approximately 365.71million women above 15 
years of age are at risk of developing cervical cancer. Currently approximately 132,000 
new cases diagnosed and 74,000 death annually in India, accounting to nearly 1/3 of 
global cervical cancer deaths. Indian women face a 2.5% cumulative life time risk and 
1.4% cumulative death risk from cervical cancer.
[4] 
 
Till date there is no exact treatment for cancer. Mostly cancer gets diagnosed only 
at the end stage, where treatment mostly becomes resistant. Treatment includes surgery, 
chemotherapy, and radiotherapy. Chemotherapy not only kills the cancerous cells but 
also the normal cells and makes the patients more vulnerable. So, traditional medicines 
can be used to treat the patients with less or no side effects as with allopathy. 
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 HERBAL medicine is still the mainstay of about 75–80% of the world 
population, mainly in the developing countries, for primary health care because of better 
cultural acceptability, better compatibility with the human body and lesser side effects. 
Today approximately 25% of all prescription drugs are derived from trees, shrubs or 
herbs.
[5]
  
 
 Amomum subulatum is traditionally used as an appetizer. Its phytochemical 
studies have revealed that it contains flavonoids, terpenoids and it has anti-oxidant 
properties which are important for anticancer activity.
[39] 
 
A HeLA cell is a cell type in an immortal cell line used in scientific research. It is 
the oldest and most commonly used cell line. The cell line was derived from cervical 
cancer. HeLa cells, like other cell lines, are termed immortal in that they can divide an 
unlimited number of times in a laboratory cell culture plate as long as fundamental cell 
survival conditions are met (i.e., being maintained and sustained in a suitable 
environment).
[6] 
 
In Amomum subulatum antioxidant activity
[39]
 has been proved, so present study 
was undertaken to investigate invitro anticancer activity of various extracts of Amomum 
subulatum using HeLA cell line. 
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2.  OBJECTIVE 
 
 To identify the Phytochemical constituents of various extracts of fruits of 
Amomum subulatum 
 To evaluate the cytotoxic activity of ethanolic extract of fruits of Amomum 
subulatum in cervical cancer cell line HeLa and to establish IC50 concentration.  
 To evaluate the Apoptotic effect of ethanolic extract of fruits of Amomum 
subulatum.  
 To study the Gene expression levels in Amomum subulatum treated HeLa 
cancerous cell line. 
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3.  REVIEW OF LITERATURE 
 
3.1 CANCER: 
Cancer is a condition where cells in a specific part of the body grow and 
reproduce uncontrollably. The cancerous cells can invade and destroy surrounding 
healthy tissue, including organs. 
Medical Term: Malignant Neoplasm.
[7] 
 
It is a class of disease in which a group of cells display the characteristics of 
 Uncontrollable Growth [Growth and division beyond normal limits]  
 Invasion [Intrusion on and destruction of adjacent tissues]  
 Metastasis [Spread to other locations in the body via lymph or blood]  
 
 Cancer sometimes begins in one part of the body and spreads to other areas, 
called as metastasis.
[8] 
 
3.2 CANCER CLASSIFICATION: 
There are four main cancer classification namely, 
 Carcinoma : The abnormal cells start their growth in the epithelial tissues. Eg . 
cancers of lungs, prostate, colon, pancreas, breast, cervical cancer. 
 Sarcoma :  Tumour grows in soft connective or supportive tissues. Eg . cancers 
of bone, muscles, nerves, fibrous tissues, blood vessels. 
 Lymphoma : Tumour that develops in the lymphocytes of immune system, 
usually in lymph nodes. Eg . non-Hodgkin’s lymphoma. 
 Leukemia:  The location of cancerous cells is the bone marrow. It affects blood 
cells. Eg . ALL, CLL, AML, CML.
[9]
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3.3 CAUSES: 
 Cancers are primarily caused due to environmental factors (90-95%) and due to 
genetic factors(5-10%). Common environmental factors that contribute to cancer include 
 
 Tobacco (25-30%)  
 Diet and Obesity (30-35%)  
 Infections (15-20%)  
 Radiation (up to 10%)  
 Stress, lack of physical activity  
 Environmental pollutants.
[10] 
 
Cancer pathogenesis is linked to DNA mutation that impact cell growth and lead 
to metastasis. Substances causing DNA mutations are mutagens and mutagens that cause 
cancers are known as Carcinogens. There exist a strong link between tobacco use and 
cancer in the lung, larynx, head, neck, stomach, bladder, kidney, oesophagus and 
pancreas. Tobacco smoke contains nearly fifty known carcinogens, responsible for 
about one in three of all cancer deaths in developed world. 
 
Diet, physical activity and obesity contribute to 30-35% of cancer death. 
Physical inactivity contributes to cancer risk by having negative effects on immune 
system and endocrine system apart from body weight. Diets low in vegetables, fruits and 
whole grains, high in processed or red meat are linked with number of cancers. Eg. Betel 
nut chewing with oral cancer, high salt diet linked to gastric cancer.
[11] 
 
Infectious diseases contribute to 18% of cancer death worldwide. Viruses are 
usual infectious agents, but bacteria and parasite too have their contribution. Viruses that 
cause cancer are termed as Oncovirus.  
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 Eg. Human papilloma virus [Cervical carcinoma], Hepatitis B and C virus 
[Hepatocellular carcinoma 
 
 Invasive cancers of about 10% are related to radiation exposure including both 
ionizing and non-ionizing radiation. 
 
 3 to 10% of cancers are due to inherited genetic defect. Eg . breast cancer and 
ovarian cancer(75%) is due to inherited mutations in genes BRCA1 and BRCA2.
[10,11] 
 
3.4 INCIDENCE AND MORTALITY OF CANCER:
[12] 
 Cancer is a leading cause of death worldwide and accounting for 7.6 million deaths 
in 2008. 
 
The main types of cancer are: 
 Lung(1.37 million deaths) 
 Stomach(736000 deaths) 
 Liver(695000 deaths) 
 Colorectal(608000 deaths) 
 Breast(458000 deaths) 
 Cervical cancer(2,88,000 deaths) 
 
 70% of all cancer deaths occurred in low and middle income countries. Cervical 
cancer is the 3
rd
 most common cancer in women. 
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3.5 CERVICAL CANCER 
DEFINTION: 
Cervical cancer is a malignant neoplasm arising from cells originating in the 
cervix uteri. Cervix is the lower, narrow portion of the uterus where it joins with the top 
end of the vagina. 
 
3.6 TYPES OF CERVICAL CANCER:
[13] 
 Squamous cell cancer 
 Adenocarcinoma 
 
 Squamous cells are the flat skin like cells that cover the outer surface of the 
cervix. Squamous cell cancer is most common type. 
 
 Adenomatous cells are gland cells that produce mucus. The cervix has these 
gland cells scattered along the inside of the passageway that runs from the cervix to the 
womb. 
 
3.7 CAUSES OF CERVICAL CANCER:
[14] 
HUMAN PAPILLOMAVIRUS: 
Human papillomavirus type 16 and 18 are the cause of 75% of cervical cancer 
globally. Woman who have many sexual partners have greater risk. 
 
According to American cancer society and other organizations the patient must 
have been infected with human papillomavirus to develop cervical cancer and is hence a 
sexually transmitted disease. 
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CIN is usually the result of an infection from the human papilloma virus (HPV). 
HPV is a very common virus that can affect the cells of the cervix. It’s mainly passed on 
during sex. 
 
Having sex at an early age and having several sexual partners can increase the 
risk of catching HPV and developing cervical cancer. 
But many women who have only had one sexual partner have HPV at some point 
in their life, and may go on to develop CIN or cervical cancer. 
 
SMOKING: 
Smoking has also been linked to the development of cervical cancer. Female 
smoker has a higher chance of CIN3 (cervical intraepithelial neoplasia) is a potentially 
premalignant transformation and abnormal growth of squamous cells on the surface of 
the cervix lead to cancer most of them have assistance of human papillomavirus. 
 
A WEAKENED IMMUNE SYSTEM 
Having a weakened immune system may allow CIN to develop into cancer. The 
immune system can be weakened by smoking, a poor diet and infections such as 
HIV/AIDS. 
 
3.8 PATHOPTHYSIOLOGY: 
Cancer is generally a disease attributed to failure of regulation of tissue growth. 
For a normal cell to transform into cancerous cell, the genes which regulate the cell 
growth and differentiation must be altered. Oncogenes and Tumour suppressor genes 
are two types of cancer genes. Oncogenes are genes that positively influence tumour 
formation, whereas tumour suppressor genes are those that negatively impact 
tumour growth. Both oncogenes and tumour suppressor genes exert their effect on 
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tumour growth through their ability to control cell division (cell birth) or cell death 
(apoptosis). Normal function of tumour suppressor gene is usually to restrain cell growth 
and this function is lost in cancer. 
 
Genetic changes can occur at different levels and by different mechanisms. Gain 
or loss of an entire chromosome can occur through errors in mitosis. More common are 
mutations which are changes in the nucleotide sequence of genomic DNA. Large scale 
mutations involve the deletions and insertions which affects the expression of the gene. 
Mutation in the error correcting machinery of a cell might cause that cell to accumulate 
errors more rapidly. Mutation in oncogenes might cause the cell to reproduce more 
rapidly and more frequently than normal cells. Mutation causes loss of tumour 
suppressor genes, which disrupts apoptosis signalling pathway and makes the cell 
immortal.
[15] 
 
p53 
 p53 is known by names like ‘tumour protein 53’ or ‘protein 53’. It is a tumor 
suppressor protein present in humans and it is encoded by gene TP 53 which is located in 
the 17th chromosome. It plays a significant role in regulation of cell cycle and helps in 
preventing cancer. It plays a major role in preventing the mutation of genome and has 
been rightly described as ‘guardian of genome’. 
 
 p53 gene is not active in cells were DNA has not been damaged. In case of DNA 
damage, it suspends the cell cycle until the damage has been repaired. If there is a 
mutation in p53, the cell cycle continues without any restriction and also reproduces the 
damaged DNA leading to uncontrolled cell proliferation finally ending up in Cancer. 
 
10 
 
Apoptosis induced by p53 involves the role of many mediators, important one 
being bax protein. Bax protein is a member of Bcl-2 protein family. p53 binding site 
located in the regulatory region of the gene which directly activates transcription of Bax 
gene and when over expressed Bax induces apoptosis.
[16] 
 
Bcl-2: 
 When the homeostatic balance between the cell growth and cell death is 
disturbed, it leads to development of cancer. Apoptosis is the process of programmed cell 
death, when altered gives rise to a number of human diseases like cancer, autoimmune 
disorders and some viral infections. Bcl-2 and its family of proteins play a significant 
role in regulation of Apoptosis. 
 
 Bcl-2 family includes both pro and anti-apoptotic proteins. Anti-apoptotic 
proteins of this family includes Bcl-2, Bcl-xL, Mcl-1, Bcl-w and A-1 which suppresses 
the cell death, whereas pro-apoptotic proteins of this family includes Bax, Bak, Bik, Bad 
and Bid which causes promotion of cell death. 
 
 Bax gene was the first pro-apoptotic member of the Bcl-2 family, which 
promotes apoptosis by competing with Bcl-2. Tumour suppressor protein p53 up 
regulates the expression of Bax and Bax is proven to be involved in apoptosis mediated 
by p53. Majority of Bax is found in cytosol and upon initiation of apoptosis; it undergoes 
a conformation shift and fits into outer mitochondrial membrane. Further it results in the 
release of cytochrome c and other pro-apoptotic factors from mitochondria leading to 
apoptosis.
[17] 
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P21: 
 p21 is a potent cyclin-dependent kinase inhibitor (CKI). The p21 protein binds to 
and inhibits the activity of cyclin-CDK2, -CDK1, and -CDK4/6 complexes, and thus 
functions as a regulator of cell cycle progression at G1 and S phase. In addition to growth 
arrest, p21 can mediate cellular senescence. The expression of this gene is tightly 
controlled by the tumor suppressor protein p53, through which this protein mediates the 
p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. 
 Growth arrest by p21 can promote cellular differentiation. p21 therefore prevents cell 
proliferation. 
 
Rb PROTEIN: 
 The Rb protein plays a key role in regulating the cell cycle. It is expressed in 
every cell type, where it exists in an active hypophosphorylated and in active 
hyperphosphorylated state. In its active state, Rb serves as a brake on the advancement of 
cells from the G1 to the S-phase of the cell cycle. If Rb is lost or made nonfunctional 
through mutation, this brake on the cell cycle is released and cells move into S-phase 
unrestrained. Specifically, Rb normally binds to and inactivates the E2F transcription 
factor. Loss of Rb results in activation of E2F. E2F binds the promoter of the cyclin E 
gene and in turn causes increased expression of the cyclin E gene and synthesis of Cdk2-
cyclin E complexes, which then drives the cell cycle.
[18,19] 
 
In cervical cancer E6 and E7 are human papillomavirus proteins which enhances 
P53 degradation causing a block in apoptosis and decreased activity of the P21 cell cycle 
inhibitor. E7 associates with P21 and prevents its inhibition of cyclin-CDK4 complex. 
E7 can bind to RB proteins removing cell cycle restriction. The net effect of E6 and E7 
proteins is to block apoptosis and remove the restraints to cell proliferation.
[20,21] 
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3.9 SYMPTOMS OF CERVICAL CANCER 
Very early-stage cervical cancer may have no symptoms. This means it is 
important to attend regular cervical screening, so that any cell changes can be picked up 
early. 
 
The most common symptom of cervical cancer is abnormal vaginal bleeding, 
usually between periods or after sex. 
 
Postmenopausal may find they have some new bleeding. 
 
Symptoms of cervical cancer can also include a smelly vaginal discharge and 
discomfort during sex.
[22] 
 
3.10  STAGING AND TREATMENT OF CERVICAL CANCER:
[23,24,25,26,27] 
STAGE 0 CANCER:  
Carcinoma in situ is treated with local ablative or excisional measures such as 
cryosurgery, laser ablation, and loop excision. Surgical removal is also preferred. After 
treatment these patients require lifelong surveillance. 
 
STAGE I  - A1 CANCER: 
The treatment choice for this stage is surgery. Total hysterectomy, radical 
hysterectomy and conisation are accepted procedure. 
 
According to National comprehensive cancer network (NCCN) guidelines, pelvic 
radiation therapy is currently a category 1 recommendation for women with stage IA 
disease and negative lymph nodes after surgery who have high-risk factors (eg, a large 
primary tumour or lymphovascular space invasion) 
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STAGE I  -  A2, IB, OR IIA CANCER: 
 Patients with stage IB or IIA disease, there are 2 treatment options 
 Combined external beam radiation with brachytherapy. 
 Radical hysterectomy with bilateral pelvic lymphadenectomy. 
 
Radical vaginal  cervicectomy, with pelvic lymph node dissection is appropriate 
for fertility preservation in women with stage IA2 disease and those with stage IB1 
disease whose lesions are 2cm or smaller. 
 
 For patients with IB2 or IIA cancer and tumours larger than 4cm, radiations and 
chemotherapy is selected in most cases. 
 
STAGE IIB, III OR IVA CANCER: 
 For locally advanced cervical carcinoma (stage IIB, III and IVA), radiation 
therapy was the treatment of choice for many years.  
 
The use of cisplatin – based chemotherapy in combination with radiation has 
become the standard of care for primary management of patients with locally advanced 
cervical cancer. 
 
STAGE IVB AND RECURRENT CANCER: 
 Radiation therapy is used alone for control of bleeding and pain, whereas 
systemic chemotherapy is used for disseminated disease. For disease recurring after 
chemotherapy and radiation therapy, a disease – free interval of more than 16 months is 
considered to designate the tumour as platinum sensitive. The standard care is 
chemotherapy with a paclitaxel and cisplatin. 
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3.11  PLANT PROFILE 
Plant name  : Amomum subulatum 
Family  : zingiberaceae 
Genus   : Amomum 
 
Vernacular names : 
 English :  Great Indian cardamom 
 Hindi  : Bari iliachi 
 Tamil  : Katu elam 
 Telugu : Nalla elakulu 
 Malayalam : Kattelam 
Habitat  :  Mountainous areas 
Habit   :  Perennial bush 
Part used  : Fruit 
 
DESCRIPTION: 
 It is a perennial bush of the ginger family, with sheathed stems reaching 10-12 
feet in height.  It has a large tuberous rhizome and long, dark green leaves 30-60 cm (1-2 
ft) long, 5-15 cm (2-6”) wide. Trailing leafy stalks grow from the plant base at ground 
level, these bear the seed pods. The flowers are white with blue stripes and yellow 
borders. The fruit is a small capsule with 8 to 16 brown seeds; the seeds are used as a 
spice.
[28] 
 
CHEMICAL CONSTITUENTS: 
 Chemical constitutes present are flavonoids, carbohydrates, amino acids, 
triterpenoids, glycosides, tannins, 1,8 cineole, limonene, terpinenes, pinenes, gallic acid,  
protocatechuic acid.
[28] 
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USES: 
The most common use of Larger or Greater Cardamom is as a mouth freshener. 
 It is used in the cure of dyspnoea, cough, itching, abdominal pain. 
 Its seeds are credited with stimulant, stomachic and astringent properties. 
 It is used to treat and prevent sore throats. 
 It is also prescribed in the treatment of indigestion and nausea. 
 It is used as antispasmodic. 
 
 The essential oil, obtained from the steam distillation of the crushed seeds of 
Larger Cardamom, contain cineole. Cineole gives the herb its aroma as well as its 
digestive and appetizer properties. 
 
  Its antioxidant properties have been reported in the Journal of the Association of 
Physicians in India.
[28]
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Figure-1: Plant of Amomum subulatum 
 
 
Figure-2: Seeds of Amomum subulatum 
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3.12 PHARMACOLOGICAL ACTIVITY IN Amomum subulatum:
[28,29,30,31] 
 
Analgesic activity; 
 Shukla et al.,(2010) reported Methanolic extract of seeds of A. subulatum at dose 
100 and 300 mg/kg and ethyl extract at dose of 200 and 400 mg/kg, showed significant 
(p<0.001) analgesic effect. 
 
Anti-inflammatory: 
 Alam et al,.(2011) reported the ethanolic and aqueous extract showed anti-
inflammatory activity with a dose of 100mg/ml and 200mg/ml respectively . 
 
Anti-microbial activity:  
 Kumar et al,.(2010) reported A. subulatum has a wide variety of secondary 
metabolites such as tannins, alkaloids and flavonoids having antimicrobial activities. 
Petroleum ether extracts of large cardamom showed antimicrobial activity and were 
found active on Staphylococcus aureus, Escherichia coli (-ve) and Pseudomonas 
aeruginosa (-ve) bacteria. 
 
 Aneja and joshi.,(2009) reported the acetonic, methanolic and ethanolic extracts 
of A.subulatum showed antimicrobial inhibitory activity against two bacteria causing 
dental caries, Streptococcus mutans and S. aureus and two fungi Candida albicans and 
Saccharomyces cerevisiae. 
 
 Jain and agarwal.,(1976) reported the essential oil from seed was found to have 
significant inhibitory effect against various keratinophilic and dermophytic fungi. 
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Antioxidant activity: 
 Verma et al.,(2010) and kikuzaki et al.,(2001) Antioxidant is the term used to 
describe a dietary component that can function to decrease tissue damage by reactive 
oxygen. Antioxidants thus have great value in preventing the oxidative diseases such as 
chronic fatigue, premature ageing symptoms, degenerative cardiovascular and 
neurovascular diseases associated with ageing . The 1,8-ceineoil and alphaterpineol, 
protocatechualdehyde and protocatechuic acid present in the seeds of A. subulatum 
showed antioxidant activity and has potential health benefits by inhibiting lipid 
peroxidation . The seed has antioxidant activity on hepatic and cardiac antioxidant 
enzymes and is attributed to their ability to activate antioxidant enzymes. 
 
Antiulcer activity: 
 Jafari et al.,(2001) reported Crude methanolic extract of the fruits of 
A.subulatum shows antiulcer activity. 
 
 Sen et al.,(2009) reported methanolic fraction, petrol soluble fraction, ethyl 
acetate soluble fraction, ethyl acetate soluble fraction produces significant ulcer 
protection against ethanol induced ulcer. 
 
 Farah et al.,(2009) reported essential oil of A. subulatum inhibit ulcer formation 
by 60.91% (p<0.001), significantly in ethanol and aspirin induced gastric ulcer. 
 
Cardio-adaptogen activity: 
 Verma et al.,(2010) reported A. subulatum has protective effect against the effect 
of acute or severe stress induced myocardial damages . Regular consumption of greater 
cardamom may therefore be useful in treatment for patients with Ischemic Heart Disease 
(IHD), facing regular stressful conditions. 
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Hypolipidaemic activity: 
 Hafidh et al.,(2009) reported that large cardamom has significant ability to 
suppress lipid peroxidation due to the presence of polyphenol content.  A. subulatum 
supplementation increases the antioxidant enzyme activities, and the lipid conjugated 
dienes and hydroperoxides. 
 
 Yadav and bhatnagar (2007) reported the inhibition of lipid peroxidation in rat 
liver homogenate due to their polyphenol content, strong reducing power and superoxide 
radical scavenging activity. 
 
Acute toxicity studies: 
 Acute toxicity study was conducted for methanolic extract of A.subulatum seeds 
by stair case method following OECD guidelines-425 , 2001. There was no lethality 
observed up to a dose of 3000mg/kg. 
 
Hepatoprotective activity: 
 Mihir parmar, purvi shah, vaishali Thakkar, Tejal R. Gandhi.,(2009) The 
hepatoprotective activity of methanolic extract of A. subulatum against ethanol induced 
hepatotoxicity in albino wistar rats. Hepatoprotective activity o of methanolic extract of 
A. subulatum  were evaluated by estimation of SGOT, SGPT, ALP,  TP, total bilirubin 
and direct bilirubin in treated rats. A. subulatum seeds significantly reduced SGPT, 
SGOT, ALP and increased TP levels indicating their hepatoprotective activity. 
 
Anti-diabetic activity: 
 Patel Amit et al.,(2012) Anti-diabetic activity of Amomum subulatum  Seed was 
evaluated in fructose fed metabolic syndrome in rat. Oral administration of acetone and 
methanol extract  of  A. subulatum extracts revealed a significant increment of serum 
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insulin levels, higher reduction in hyperglycemia when compared to the diabetic control 
rats . The histological studies of the endocrine region of pancreas of diabetic animals 
revealed that shrinkage of β cells of islets of langerhans. Animals treated with both 
extracts of A. subulatum, revealed restoration of β-cells. This activity of acetone and 
methanolic extract might be due to presence of phenolics like protocatechuic acid. 
 
3.13 HeLa cell line: 
 The HeLa cell line is an immortal cancer cell line. It is termed "immortal" 
because the cells can replicate indefinitely in culture. The original cells came from a 
visible malignant cervical tumor in the body of a 31-year-old African American woman 
named Henrietta Lacks. The cells were taken early in 1951 and given to Dr. George Gey, 
who produced the original cell line. Henrietta Lacks died the same year, in October, from 
the very cancer cells that have since been used to save thousands and thousands of lives. 
 
 Now there are many strains of HeLa cells all over the world that have evolved in 
cell culture, and it is estimated that more HeLa cells have been cultured than were in 
Henrietta Lacks body to begin with.
[32] 
 
MTT ASSAY: 
 Sheng-hua zhang et al.,(2007) soyasaponins are present in legumes and 
soyabeans are the primary dietary source of saponins. SS-II the second fraction of 
soyasaponins, was separated by column chromatographic method with D101 A 
macroporous resin from soyabean. Study at the concentration range of 100-400 mg/L, 
SS-II had obvious cytotoxic effect on Hela cells by MTT assay.
[33] 
 
 Aied M Alabsi et al.,(2012) In this study, goniothalamin, a natural occurring 
styryl-lactone extracted from Goniothalamus macrophyllus, was investigated for 
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cytotoxic properties against cervical cancer (HeLa), breast carcinoma (MCF-7) and colon 
cancer (HT29) cells as well as normal mouse fibroblast (3T3) using MTT assay. 
Fluorescence microscopy showed that GTN is able to induce apoptosis in HeLa cells in a 
time dependent manner.
[34] 
 
 Sanjay patel et al.,(2009) The study was aimed to evaluation of the anticancer 
activity of the fruits of Solanum Nigrum on the HeLa cell line. The fruits of Solanum 
Nigrum methanolic extract were tested for its inhibitory effect on HeLa Cell Line. The 
percentage viability of the cell line was carried out by using Trypan blue dye exclusion 
method. The cytotoxicity of Solanum Nigrum on HeLa cell was evaluated by the SRB 
assay and MTT assay. Solanum Nigrum methanolic extract has significant cytotoxicity 
effect on HeLa Cell Line in concentration range between 10 mg/ml to 0.0196 mg/ml by 
using SRB assay and study also showed that inhibitory action on HeLa cell line in 
concentration range between 10 mg/ml to 0.0196 mg/ml by using MTT assay.
[35] 
 
Fluorouracil (5FU) : 
 Ali Alshehri et al.,(2012) reported the antiproliferative effect of Cinchorium 
endivia L. phenolic extracts on breast cancer cell line MCF-7. Anticancer activity of 
methanolic extract of root of C.endivia, L was evaluated on breast cancer cell line MCF-
7 and was compared with anticancer standard drug 5 FU (5 Fluorouracil). MTT assay 
was used to study the cytotoxicity of the root extract and standard drug. IC50 value was 
found out to be 401μg/ml for root extract and 0.67 μg/ml for standard 5 FU.[36] 
 
Kameshwaran et al., (2012) reported the anticancer activity of methanolic 
extract of Tecoma stans flowers. The anticancer activity of methanolic extract of T.stans 
was evaluated by both in vitro and in vivo methods. Cytotoxicity assay was performed 
with Vero and Hep2 cell lines using MTT assay and it was compared with standard 5 
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Flourouracil, whose cytotoxicity was found to be 85.78% in Vero cell line and 81.53% in 
Hep 2 cell line.
[37] 
 
P53:  
 Role of p53 in human cancers have been studied extensively in the past decades 
and restoring wild type p53 has been a major target in cancer therapy. 
 
 Anjana munshi et al.,(2009) reported the apoptotic effect of chloroform, n-
hexane and methanolic extracts of Nigella sativa on HeLa cells which contained certain 
compounds which up regulate the expression of p53.
[38] 
 
Bcl2: 
 Gul Ozcan Arican.,(2012) reported the effect of Astragalus L root extract on 
proliferation of He La cells and Bcl-2 gene expressions. Cytotoxic effect of ethyl acetate 
extract of root was investigated using MTT assay and the extract was reported to possess 
cytotoxic effect on HeLa cells. Effect of root extract on gene expression rates involved in 
apoptosis was studied using RT-PCR technique. Anti apoptotic gene Bcl-2 was found to 
be expressed at a dose of 1 mg/ml for a treatment up to 24 hours and this expression was 
disappeared when the treatment was extended up to 48 hours.
[39] 
 
Microscopic Studies: 
 Shruti Nair et al.,(2011) reported the anticancer activity of alcoholic and 
aqueous extracts of Moringa oleifera on Hela cells. Anti proliferative effect was assessed 
by MTT assay and apoptosis of cancer cells were confirmed by DNA fragmentation test 
and ethidium bromide-acridine orange staining. It was reported that staining the cells 
which was treated with different concentrations of Moringa oleifera aqueous extracts 
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showed viable cells green with intact nuclei and non viable cells with bright orange 
chromatin.
[40] 
 
Apoptotic DNA Fragmentations:  
 Apoptosis also known as ‘programmed cell death’ is the elimination of no longer 
wanted cells in an active and inherently controlled manner. Characteristic of apoptotic 
process are:  
 Cell and nuclear shrinkage  
 Chromatin condensation  
 Formation of apoptotic bodies[41]  
 
 DNA fragmentation in cells undergoing apoptosis is caused by enzyme namely 
Caspase Activated DNase or CAD, which is inhibited by another protein namely 
Inhibitor of Caspase Activated DNase or ICAD. During apoptosis CAD is activated by 
apoptotic effector caspase, caspase 3. CAD is usually complexed with ICAD in 
proliferating cells. In cells where apoptosis is induced, caspase 3 cleaves the CAD:ICAD 
complex thereby allowing CAD to cleave the chromosomal DNA into nucleosomal 
fragments leading to apoptosis. Many chemotherapeutic drugs like mitomicin C induce 
apoptosis by causing damage to nuclear DNA. Cleavage of chromosomal DNA into 
oligonucleosomal fragments is a late event of apoptosis.
[42] 
  
 Kanimozhi D et al., DNA fragmentation was obtained by agarose gel 
electrophoresis of ethanolic extract of Cynodon dactylon with Hep-2, HeLa and Mcf-7 
cancer cell lines. The DNA migrated as discrete bands which was compared to DNA 
markers, gave a ladder of approximately 200 base pair (bp). Such DNA ladders are 
considered to be a hall mark of apoptosis, continues smears may also indicate DNA 
fragmentation due to apoptosis. The ladder from DNA fragmentation catalyzed by an 
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endogenous endonuclease that cleaves internucleosomal DNA to form ladder like bands 
of oligo nucleosome fragments. From this it is revealed that these DNA fragments (fig.3) 
shows that the ethanolic extract of Cynodon dactylon has anticancer activity in the Hep-
2, HeLa and Mcf-7 cell lines.
[43]
  
 
Real Time RT-PCR 
 Ali Alshehri (2012) reported the anti proliferative effect of Cinchorium endivia 
L, phenolic extract on cancer cell line HCT-116. The anticancer activity of the plant root 
extract was studied on colon cancer cell line HCT-116. Cytotoxicity was measured and 
compared with 5 FU. Gene expression levels of cancer markers p53, Bcl-2, TNF-α and 
immune response markers IL-2, 4 and 6 along with housekeeping gene primer GPDH 
were studied using real time RT- PCR , SYBR green model. It was reported that p53 
expression was found to be same in control and treated cells. Bcl2 expression was low in 
treated cells when compared to control. TNF expression was found to be same in cells 
treated with 5 Fluorouracil and control, but higher in cells treated with plant extract.
[44] 
 
Ali A Alshatwi et al.,(2011) reported the anti tumour activity of methanolic 
extract of lemon fruit on MCF-7 breast cancer cell line. Apoptotic cell death was studied 
using TUNEL Assay. The expression levels of apoptotic genes was analyzed by reverse 
transcription PCR using a real time SYBR green gene expression assay kit. It was 
reported that p53 and caspase 3 expression was increased which lead to apoptosis. 
Expression levels of pro apoptotic gene bax was increased and anti apoptotic gene Bcl2 
was decreased after treatment with lemon extract.
[45] 
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4.0 METHODOLOGY 
4.1 EXTRACTION  
 It is defined as separation of medicinally active parts of plant using selective 
solvents through standard procedure. Extraction procedure was carried out in Institute of 
Pharmacology, Madras Medical College, Chennai. 
 
4.2 PLANT PARTS USED: 
 The fruits of Amomum subulatum was used for extraction which was collected in 
month of July 2013 at Tirunelveli. It was examined and authenticated by Mr. V. 
Chelladurai, officer- Botany (scientist-c) (retd.), Central Council for Research in 
Ayurveda & Siddha, Govt. of India. 
 
4.3 SOLVENTS USED: 
Based on polarity various solvents were used such as ethanol, acetone, and water. 
 
4.4 TYPE OF EXTRACTION  
 Hot continuous (soxhlet) extraction method. 
 
APPARATUS DESCRIPTION 
The apparatus consists of body of the extractor (thimble) attached with side tube, 
siphon tube, lower end attached with distillation flask, mouth of the extractor is fixed to 
the condenser by standard joints. 
 
PRINCIPLE 
 It is a process of continuous extraction method in which the solvent can be 
circulated through the extractor for several times. The vapours of solvent are taken to the 
condenser and the condensed liquid is returned to the extract for continuous extraction.  
 
27 
 
PROCEDURE 
 50 grams of fruit was packed into soxhlet apparatus and was subjected to 
extraction sequentially with 500ml of ethanol, acetone, and water. The extraction was 
continued until the colour of the solvent in the siphon tube became colourless. 
 
 Extracts of acetone and ethanol were subjected to evaporation at room 
temperature till a semisolid mass was obtained. Aqueous extract was subjected to 
lyophilisation with the help of lyophiliser to a semisolid mass. 
 
4.5 PHYTOCHEMICAL ANALYSIS:
[46] 
The freshly prepared extracts of acetone, ethanol and water were subjected to 
phytochemical screening for the presence or absence of active phytochemical 
constituents by following methods. 
 
 Test for Steroids:  
Salkowskis test: Crude extract was mixed with 2ml of chloroform. Then 2ml of 
conc. Sulphuric acid was added carefully and shaken gently. Appearance of reddish 
brown colour ring indicated the presence of steroids 
 
Test for Flavanoids: 
Shinoda test:  Crude extract was treated with 5 ml 95% ethanol, few drops 
concentrated hydrochloric acid and 5 grams magnesium turnings, appearance of pink 
colour indicated the presence of steroid 
 
Lead acetate test: Crude extract was treated with few drops of lead acetate 
solution. Appearance of yellow colour precipitate indicate the presence of flavanoids 
 
28 
 
Alkaline reagent test: Crude extract was treated with few drops of sodium 
hydroxide solution. Formation of intense yellow color, which becomes colorless on 
addition of dilute acid, indicates the presence of flavanoids. 
 
Test for terpenoids:  
5 ml of each extract was mixed in 2 ml of chloroform. 3 ml of concentrated 
H2SO4 was then added to form a layer. A reddishbrown precipitate colouration at the 
interface formed indicated the presence of terpenoids. 
 
Test for Proteins:  
 Millions test: Crude extract was mixed with 2ml of millions reagent. Appearance 
of white precipitate which turns red on gentle heating, indicates the presence of proteins. 
 
Test for Glycosides:  
 Liebermann’s test: Crude extract was mixed with 2ml of chloroform and 2ml of 
acetic acid. Mixture was cooled in ice and conc. sulphuric acid was added. Colour 
change from violet to blue to green indicates the presence of steroidal nucleus 
 
Test for Carbohydrates:  
 Fehling’s test: Crude extract was treated with equal volume of Fehling A and 
Fehling B reagents and mixed together and gently boiled. Appearance of brick red 
precipitate at the bottom of the test tube indicate the presence of reducing sugars 
 
Test for phenols and tannins:  
 Crude extract was mixed with 2ml of 2% solution of ferric chloride. Appearance 
of violet colour indicates the presence of phenolic compounds and tannins. Crude extract 
was dissolved in water and treated with 10% of lead acetate solution, appearance of 
white precipitate indicate the presence of tannins and phenolic compounds.  
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Test for alkaloids:  
 Crude extract was treated with few drops of dilute hydrochloric acid and filtered. 
The filterate was tested with various alkaloidal reagents such as 
 
Mayer’s reagent – Cream precipitate  
Dragendroff’s reagent –Orange brown precipitate 
Wagner’s reagent–Reddish brown precipitate 
 
4.6 PREPARATION OF MEDIA 
Definition 
 Media is a nutritional supplementation essential for maintenance, growth and 
division of cells in-vitro. 
 
Materials required 
1. Minimum essential medium (MEM) in powder form.  
2. Penicillin (100 IU/ml)  
3. Streptomycin (100 μg/ml)  
4. Phenol red  
5. Amphotericin B  
6. L-glutamine (3%)  
7. Foetal bovine serum (FBS) 10%  
8. Sodium bicarbonate (7.5 %) 
 
Procedure:  
 Powder form of MEM was dissolved in one liter of pre sterilized Millipore 
distilled water, mixed well and closed.  
 The medium was sterilized for 15 minutes at 121°c.  
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 856 ml of sterilized MEM was taken in a 1000 ml flask and to it each ml of 
penicillin, streptomycin, phenol red and amphotericin B was added and mixed 
well.  
 10 ml of 3% L-glutamine, 100 ml of FBS and 30 ml of 7.5% sodium bicarbonate 
was added to make up the volume to 1000 ml.  
 pH was adjusted to 7.2 – 7.4 and the medium was stored for two days at 37°c and 
the pH was checked and transferred to the refrigerator.  
 
4.7 CELL LINES AND CULTURE 
 HeLa Cell line was obtained from Tamil Nadu Veterinary College, Chennai. The 
cells were maintained in Minimal Essential Media supplemented with 10% FBS, 
penicillin (100 U/ml), and streptomycin (100 μg/ml) in a humidified atmosphere of 50 
μg/ml CO2 at 37 °C. 
 
4.8 SUB-CULTURING ADHERENT CELLS:
[47] 
Materials Required:  
1. Incubator (37°c, 5% CO2)  
2. Laminar flow hood 
3. Minimum essential medium  
4. TPVG solution (Trypsin 2%, PBS – pH 7.4, Versene/EDTA- 0.2%, glucose10%)  
5. Tissue culture treated culture flask  
6. Micropipette  
7. Falcon tubes- conical  
8. Inverted microscope  
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Procedure:  
 The culture flask containing the adherent cells (primary culture) was removed 
from the incubator.  
 The culture flask was transferred aseptically to the bio safety cabinet along with 
minimum essential medium and TPVG solution after confirming its 90% 
confluency with the help of inverted microscope.  
 The primary culture was passaged /sub cultured to required number of culture 
flasks for  
           further study.  
 The cap of the culture flask was opened and with the help of micropipette the 
medium was aspirated from the culture flask and discarded.  
 200μl of TPVG solution was added to the culture flask and rinsed well to remove 
any adhering medium and later the solution was aspirated and discarded.  
 500-1000μl of TPVG solution was again added to the culture flask and the 
solution was spread evenly to cover the entire surface of the culture flask.  
 The flask was then incubated for 5 minutes for detachment of adhered cells from 
the monolayer (cell detachment can be viewed and confirmed under microscope 
after 5 minutes of incubation).  
 After detachment of cells from the monolayer, the culture flask was transferred 
back to the bio safety cabinet. The detached cells were suspended completely in 
the TPVG solution by re suspending it with the help of micropipette.  
 The TPVG solution containing the detached cells were aspirated from the culture 
flask and distributed into 7 new tissue culture treated culture flasks for further 
studies.  
32 
 
 5ml of fresh minimum essential medium was added to all 7 culture flask 
containing the TPVG solution with suspended cells, such that it covers the entire 
surface of the flask. 
 
4.9 CYTOTOXICITY STUDY 
MTT ASSAY:
[48] 
 It is a universally accepted in-vitro method for screening the drugs having 
cytotoxic activity. It was described by Mosmamm (1983) & Monks (1991). This assay is 
used to determine the IC50 of drugs or extracts. 
 
PRINCIPLE 
 The Tetrazolium salt, 3,-(4,5- dimethyl thiazol-2-yl)-2,5,diphenyl tetrazolium 
bromide is reduced into blue formazan product by the mitochondrial dehydrogenase 
enzyme of live or metabolically active cells. 
 
 The intensity of blue or purple colored formazan produced is directly 
proportional to cell viability. 
 
Materials required 
1. Plant extracts 
  Ethanol (1000, 500, 250, 125, 62.5, 31.2, 15.6, 7.8) 
2. Reagents 
DPBS 
TPVG  
MEM 
Tryphan blue 
MTT dye(5mg/ml) 
DMSO(0.1% v/v) 
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3. Other materials 
  MTT plate with plate with lid 
  Sterile pipette, tips, glove, mask 
  Aluminium foil 
  Incubator  
  Inverted microscope 
  Falcon tubes 
  Haemocytometer, cover slip. 
 
PROCEDURE 
 Culture flask containing the adherent cells were taken from the incubator and 
checked for its confluency.  
 After confirming the confluency, the adherent monolayer cells were detached to 
form a cell suspension by adding an ml of TPVG solution and incubating it for 5 
minutes.  
 After incubation, the TPVG solution containing cells were aspirated from the 
culture flask and transferred to the falcon tubes and was subjected to 
centrifugation at 10000 rpm for 5 minutes.  
 After centrifugation, supernatant was discarded and 1 ml of medium was added to 
the pellet of cells which have sedimented at the bottom of the tube and was re 
suspended well in the medium with the help of micropipette.  
 10μl of this cell suspension was mixed well with 10μl of tryphan blue. 
 
Cell counting:  
 After placing the cell suspension along with tryphan blue in haemocytometer, the 
numbers of cells in four corner quadrants were counted.  
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 Numbers of cells in left and right top quadrant were found to be 126 and 
147respectively. Numbers of cells in left and right bottom quadrant were found 
to be 138 and 142 respectively.  
 Total number of cells/ml were calculated as follows:  
            
126+147+138+142×2×10
4
    = 276.5×10
4cells/ml
 
          4 
 
 276.5×104 cells were present in 1 ml of cell suspension; we need to plate 26 
wells each with 100 μl containing 10000 cells/well for maintaining  triplicate 
condition for control, standard and test extracts.  
 Therefore, 276.5 x 104 cells were present in 1000 μl. 10000 cells were present in 
x μl.  
X =       10000 x 1000         =3.6µl 
                 276.5×10
4
   
 
 3.6 μl of cell suspension should be mixed with 96.4 μl of medium for plating one 
well. In order to plate 26 wells, 93.6 μl of cell suspension was mixed with 2506 
μl of medium to get a concentration of 10000 cells / 100 μl for plating the wells.   
 100 μl of this cell suspension were seeded into 26 wells of 96 well plate, and the 
plate was incubated for 24 hours at 37°c, 5% CO2 for attachment of the cells.  
 After 24 hours the seeded cells in the 96 well plate were treated with serial 
concentration of plant extract and the standard drug 5FU.  
 Plant extracts of acetone, ethanol and aqueous and standard drug were initially 
dissolved in 0.1% v/v DMSO and further diluted in serum free medium to get a 
desired concentration.  
 100 μl of each plant extract and standard concentration were added to the 96 well 
plates to get a final concentration of 1000 μg/ml, 500 μg/ml, 250 μg/ml, 62.5 
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μg/ml, 31.2 μg/ml and 15.6 μg/ml for plant extracts and 1 μg/ml, 2.5 μg/ml, 5 
μg/ml and 10 μg/ml for standard drug.  
 Final volume in each well was 200 μl and the plates were incubated again for 48 
hours.  
 Triplicate was maintained for all concentrations and the medium without 
samples were taken as control. 
 By the help of Inverted microscope Toxicity is observed. 
 
4.10 Extraction of DNA, RNA using Genei TRI Solution:  
 Extraction of DNA, RNA  from the cells which was treated with IC50 
concentration of Ethanolic extract, IC50 concentration of 5 Fluorouracil and from cells 
without any treatment were extracted as per Genei TRI Soln Protocol.
[49]
 Fully grown 
cells or 90% confluency reached 3 subcultured or passaged flask is taken. The medium 
inside the flask is aspirated and decanted while cells adhered to the monolayer was kept 
intact and the flasks were subjected to drug treatment.  
 
 Flask 1 is replaced with the fresh medium without any test or standard drug and 
it served as Control.  
 Flask 2 is treated with IC50 concentration of the effective ethanolic extract. 
 Flask 3 is treated with IC50 concentration of standard 5 fluorouracil (IC50 
confirmed from MTT Assay).  
   
 All the three flasks were incubated for 48 hours at 37°c and 5% CO2. After the 
incubation period, the medium inside the flasks were removed and the adhered cells were 
disturbed by treatment with TPVG solution and the TPVG solution containing the 
suspended cells of three flasks were stored in refrigerator for further processing 
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Extraction of RNA :  
Materials Required:  
1. Chloroform  
2. Isopropyl Alcohol  
3. 75% Ethanol  
4. RNase free water  
 
Steps Involved:  
1. Homogenisation  
2. Phase Separation  
3. RNA Precipitation  
4. RNA Wash  
5. Resuspending RNA  
 
Procedure: 
Homogenisation:  
 Cells were pelleted by centrifugation at 1200 rpm for 5 minutes.  
 The supernatant was decanted and 1 ml of TRI solution was added and mixed by 
repetitive pipetting  
 
Phase Separation:  
 The samples were incubated for 5 minutes at room temperature (without 
exceeding 30°c) to completely dissociate nucleoprotein complex.  
 0.2 ml of chloroform per 1 ml of TRI Solution was added, mixed thoroughly and 
subjected to incubation at room temperature (without exceeding 30°c) for 2-3 
minutes.  
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 The samples were centrifuged at not more than 12000 rpm for 15 minutes at 2-
8°c and the mixture thus obtained contained a lower phenol chloroform phase, 
interphase and colourless upper aqueous phase.  
 RNA was present in upper aqueous phase.  
 Volume of aqueous phase obtained was about 60% of volume of TRI Solution 
reagent used for homogenization.  
 
RNA Precipitation:  
 Aqueous phase was transferred to fresh 1.5 ml vial.  
 0.5 ml of isopropanol alcohol per 1 ml of TRI Solution was used for initial 
homogenization.  
 Samples were incubated for 10 minutes at room temperature and were subjected 
to centrifugation at 12000 rpm for 10 minutes at 2-8°c.  
 
RNA Wash:  
 Supernatant was decanted and the RNA precipitated as gel like pellet on the sides 
of 1.5 ml vial.  
 RNA pellet was washed once with 75% ethanol, at least 1ml of 75% ethanol was 
used per ml of TRI Solution reagent used for initial homogenization.  
 Solution was centrifuged at 10000 rpm for 10 minutes at 2-8°c  
 
Resuspending RNA:  
 RNA pellet was air dried and re-suspended in100μl RNase free water by passing 
solution few times through pipette tip gently  
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Extraction of DNA: 
Materials required:  
1. Ethanol (100%)  
2. 75% Ethanol  
3. 0.1 M sodium citrate in 10% ethanol.  
4. 8mM Sodium hydroxide.  
5. Wash Buffer : 0.1 N Sodium citrate in 10% ethanol.  
Steps involved:  
1. DNA Precipitation  
2. DNA Wash  
3. Re suspending the DNA pellet.  
 
Procedure: 
DNA Precipitation: 
 0.3 ml of 100% ethanol was added per 1 ml of TRI Solution used for 
homogenization to the inter phase and organic phase which was obtained during 
phase separation in RNA extraction.  
 Samples were stored at room temperature without exceeding 30°c for 2-3 
minutes.  
 Samples were centrifuged at 5000 rpm for 10 minutes at 2-8°c and DNA was 
obtained as a pellet.  
DNA Wash:  
 DNA pellet obtained was washed with wash buffer per 1 ml TRI Solution used.  
 At each wash pellet was stored in wash solution for 30 minutes at room 
temperature without exceeding 30°c with periodic mixing.  
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 Samples were centrifuged at 5000 rpm for 10 minutes at 2-8°c and the wash step 
was repeated twice.  
 Following wash, DNA pellet was suspended in 2 ml of 75% ethanol and kept for 
twenty minutes at room temperature and mixed periodically.  
 Samples were centrifuged at 5000 rpm for 10 minutes at 2-8°c.  
 
Re-suspending the DNA Pellet:  
 DNA pellet was air dried for 5-10 minutes.  
 DNA pellet was re-suspended in 300μl to 600μl of 8mM sodium hydroxide so 
that the concentration of DNA was 0.2 - 0.3μg/ml and samples were incubated at 
room temperature for 15-20 minutes  
 
4.11 MICROSCOPIC STUDIES:
[50] 
Light microscopic study  
Fluorescent microscopic study.  
 
Light microscopic studies:  
 Morphological changes in the cancer cells before and after drug treatment can be 
studied with the help of Light microscope.  
 Fully grown or 90% confluency reached subcultured or passaged flask was 
taken.  
 The morphology of the cancer cells in the flask before drug treatment were 
observed under inverted microscope and photographed.  
 The medium inside the flask was aspirated and decanted without disturbing the 
adhered monolayer of cells.  
 The culture flask was then treated with IC50 concentration of effective plant 
extract such that it covers the entire surface area  
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 The flask was then incubated for 48 hours at 5% CO2 and 37°c.  
 After incubation period, the flask was taken and observed under inverted 
microscope and the morphological changes were studied and photographed.  
 The morphological changes of the cancer cells before and after drug treatment 
were evaluated.  
 
Flourescent microscopic studies:  
 Fluorescent microscopy was used to study the viability of cells as well as nuclei 
and chromatin condensation with the help of fluorescent binding dye.  
 Fully grown or 90% confluency reached two subcultured or passaged flask was 
taken.  
 Flask 1 was used for studying the control cancer cells and flask 2 was used for 
studying the extract treated cancer cells.  
 From flask 1 the adhered cells were detached with the help of TPVG solution 
and the TPVG solution containing the cells were centrifuged and the cells were 
pelleted.  
 The pellet of cells were then resuspended in phosphate buffer saline of pH 7.4. 
100 μl of this cell suspension was introduced into microscopic slide along with 
equal mixture of acridine orange and ethidium bromide for staining.  
 The cells were then viewed under fluorescent microscope and the viability and 
nuclear changes were studied and photographed.  
 In flask 2, the medium was aspirated and decanted without disturbing the 
adhered monolayer of cells.  
 Flask was then treated with IC50 concentration of effective plant extract such 
that it covers the entire surface area.  
 The flask was then incubated for 48 hours at 5% CO2 and 37°c.  
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 After incubation period, the flask was taken and the cells were pelleted and the 
same procedure was followed as in flask 1.  
 
4.12 APOPTOTIC DNA FRAGMENTATION:
[51] 
Apoptosis is characterized by cleavage of chromosomal DNA into 
oligonucleosomal fragments. Irregularities in apoptosis have paved way for many 
diseases like cancer, autoimmune disease and neuronal degeneration. This cleavage of 
DNA or its fragmentation can be visualized by DNA laddering assay. Cleavage of 
chromosomal DNA into oligonucleosomal fragments is a hallmark of apoptosis. This 
fragmentation of DNA in cancer cells after treatment with standard drug or test extract 
can be studied with the help of Agarose Gel Electrophoresis. Electrophoresis is a method 
of separating substances based on the rate of movement under the influence of electric 
field. 
 
Materials required:  
1. Agarose  
2. 5X TAE buffer  
3. 6X loading dye  
4. DNA ladder  
5. Electrophoresis chamber  
6. Gel casting tray and comb  
7. Ethidium bromide  
8. Microwave oven  
9. Conical flask  
10. Sterile tips and pipettes  
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Procedure: 
The steps involved are:  
 Preparation of Agarose gel slab  
 Loading of samples  
 Running the gel  
 
Preparation of Agarose gel slab:  
 Gel casting tray and comb was wiped with ethanol and dried. The two open ends 
of the tray were sealed with tape.  
 Place the combs in the gel casting tray.  
 1.2 grams of agarose powder was weighed and transferred to 500 ml conical 
flask containing 100 ml of TAE buffer.  
 Agarose was melted using microwave oven until the solution became clear.  
 The solution was cooled to about 50 - 55°c by swirling the flask occasionally or 
placing it in water bath.  
 3μl of ethidium bromide was added to the solution and mixed well.  
 The gel casting tray along with comb was kept horizontally on a flat even 
surface. 
 Agarose solution was poured evenly on the casting tray such that it covers the 
entire surface evenly without any bubble formation and was allowed to cool and 
solidify into a gel slab.  
 After solidification, remove the tapes from both ends of the tray and place the 
gel in electrophoresis chamber and add enough TAE buffer so that there is 2-3 
mm of buffer over the gel and carefully pull out the comb out of the tray to form 
wells.  
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Loading of samples:  
 DNA which was extracted from the control, standard and extract treated cancer 
cells. 
 Based on the quantification, equal quantity of DNA was taken and mixed with 
required TAE buffer to make a final volume of 10μl each for a sample.  
 2 μl of 6X loading dye was added to the DNA sample and mixed well.  
 10μl of 100 base pair standard DNA ladder and 12μl of DNA samples were 
loaded carefully in the submerged wells of gel slab in the electrophoresis 
chamber  
 
Running the Gel:  
 Lid was placed on the gel box and the electrodes were connected.  
 Electrode wires were connected to power supply and power supply of about 80 
volts were applied.  
 Power supply to the electrophoresis chamber was ensured until the blue dye 
approached the end of the gel.  
 Later power supply was cut off, wires were disconnected and the lid was 
removed.  
 Gel tray was carefully taken out and the gel was placed inside the Gel 
photostation and photographed in presence of UV light  
 
4.13  REAL TIME REVERSE TRANSCRIPTASE POLYMERASE CHAIN 
REACTION:
[52]
  
 Real time reverse transcriptase polymerase chain reaction is abbreviated as qRT-
PCR. It is a technique where expression of RNA is studied by converting it into cDNA 
with the help of enzyme reverse transcriptase and quantitatively measuring the amount of 
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amplified target sequence from entire cDNA using fluorescent dye SYBR green in real 
time. Upon binding with DNA, SYBR green dye used will emit fluorescence and the 
fluorescence intensity is directly proportional to number of DNA copies or expression 
produced. The fluorescence which is emitted is analysed by detector with the help of 
LED source and it gives the relative expression of genes. The procedure was carried out 
as per Step 1 plus ABI protocol. 
 
Procedure: 
A) Complementary DNA Synthesis: 
Materials Required:  
1. 5X buffer  
2. 10mm dNTPs  
3. Hexamer primer  
4. Extracted RNA  
5. Thermal cycler  
6. Reverse transcriptase  
7. DTT  
 
Procedure:  
 In 200μl eppendorf tubes, 5μl of 5X buffer, 2μl of 10mm DNTPs and 1.5μl of 
hexamer primer was added.  
 Later 15μl of extracted RNA was added and the eppendorf tubes were kept in 
thermal cycler at 70°c for 5 minutes to separate the false double stranded RNA.  
 The tubes were taken out and immediately cooled with ice to prevent binding of 
false double stranded RNA again.  
45 
 
 1.5μl of Reverse transcriptase and 1μl of DTT was added to the tube and spun 
for few seconds.  
 It was then placed in thermal cycler , 25°c for 5 minutes, for binding of hexamer, 
followed by 42°c for 45 minutes for cDNA synthesis, followed by 85°c for 5 
minutes for denaturation of remaining unconverted RNA’s and finally at 4°c for 
5 minutes  
 
B) Primer synthesis: 
 The primers synthesized were P53, Bcl2, along with house keeping gene GPDH. 
The primers were synthesized by Geno Rime with the help of Primer express software 
with the available primer sequence. 
 
 The concentration of primers synthesized were 100pM/μl. It was diluted in the 
ratio of 1: 10 with water to get a concentration of 10pM/μl 
 
C) Real time PCR:  
 The materials required are  
 25μl of SYBR green 
 RT mix 
 5μl of cDNA 
 2μl of 25 pM/μl forward primer 
 2μl of 25 pM/μl reverse primer 
 16μl PCR grade water. 
 
 For a total of 50 μl reaction, the above mentioned mixtures were added into 
eppendorf tubes and they were placed in real time PCR instrument and the 
program was set as follows:  
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 Step 1: Pre denaturation at 95˚C for 1 minute 
 Step 2: Denaturation at 95˚C for 15 seconds 
 Step 3: Annealing at 60˚C for 15 seconds 
 Step 4: Extension at 72˚C for 45 seconds  
 Step 2 to step 4 repeated for 40 cycles.  
 The relative expression of genes was analyzed and interpreted and by Applied 
Biosystem Software.  
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5. RESULTS 
 
 
 
Table 1. Phytochemical analysis of various extracts of fruits of Amomum subulatum. 
 
 
Constituents Ethanol extract Acetone extract Aqueous extract 
Proteins Present Present Present 
Carbohydrates Present Present Present 
Glycosides Present Present Present 
Triterpenoids Present Absent Absent 
Flavanoids Present Absent Absent 
Alkaloids Absent Absent Absent 
Steroids Present Present Present 
Phenols and tannins Present Present Present 
 
 
 
Table 2. Percentage yield of extracts 
Extract % yield 
Ethanol 5.20 
Acetone 3.45 
Aqueous 6.40 
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5.1 CYTOTOXICITY TEST  
 
 MTT assay was carried out with ethanolic extract of Amomum subulatum and 
with 5 Fluorouracil and the results are shown in Table 3 & 4. 
 
Table 3. MTT assay of ethanolic extract of Amomum subulatum 
S.No 
Concentration 
(µg/ml) 
Dilutions 
Absorbance 
(O.D) 
Cell viability 
(%) 
1 1000 - 0.07 11.86 
2 500 1:1 0.13 22.03 
3 250 1:2 0.19 32.20 
4 125 1:4 0.22 37.28 
5 62.5 1:8 0.28 47.45 
6 31.2 1:16 0.34 57.62 
7 15.6 1:32 0.39 66.10 
8 7.8 1:64 0.44 74.57 
9 Cell control - 0.59 100 
 
 
IC50 concentration and Percentage cell viability 
                  
 
 Figure 3. Graphical representation of % cell viability vs concentration (µg/ml) of 
ethanolic extract of Amomum subulatum. 
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IC50 concentration and % cell viability of 5 Fluorouracil 
 Table 4. MTT Assay of 5 Fluorouracil 
S.No 
Concentration 
(µg/ml) 
Dilutions 
Absorbance 
Cell viability (%) 
(O.D) 
1 1000 - 0.01 1.85185185 
2 500 1:01 0.03 5.55555556 
3 250 1:02 0.06 11.1111111 
4 125 1:04 0.1 18.5185185 
5 62.5 1:08 0.13 24.0740741 
6 31.2 1:16 0.17 31.4814815 
7 15.6 1:32 0.2 37.037037 
8 7.8 1 64 0.28 51.8518519 
9 Cell control - 0.54 100 
 
 
 
 
 
Figure 4: Graphical representation of % cell viability vs Concentration in μg/ml of 
5 Fluorouracil 
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Anticancer effect of Sample on HeLa Cell line using microscope 
 
Normal HeLa cell line 
 
Toxicity-1000µg/ml
 
Toxicity-125µg/ml 
 
Toxicity-62.5µg/ml 
 
Toxicity-31.2µg/ml 
 
 
Figure 5. When HeLa cell line was treated with plant extract the cell death was more at 
1000µg/ml and the least was at the concentration of 31.2µg/ml 
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5.2  MICROSCOPIC STUDIES FOR APOPTOSIS: 
Light microscopic observation:  
 Destruction of monolayer was observed in cells treated with IC50 concentration 
of ethanolic extract of amomum subulatum. The observations were compared 
with the cells without any treatment.  
 Reduction of HeLa cell population and detachment of dead cells were observed 
in treated cells when compared to control cells.  
 Loss of integrity of the membrane resulting in crooked and vesicle shape of the 
membrane, reduction in cell volume, cell shrinkage and chromatin condensation 
were observed in cells treated with extract when compared to control.  
 
Flourescence microscopic observation:  
 Control cells without any drug or extract treated were bright green in colour.  
 Cells treated with ethyl acetate extract of Amomum subulatum were bright orange 
in colour with loss of membrane integrity and cytoplasmic contents leaking out of 
the cell. 
 
 The observations of light microscopic studies and fluorescent microscopic studies 
are depicted in figures 6 and 7 
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Figure 6 . Light Microscopic study images 
  
 
A) HeLa cells – Control 
 
B) HeLa cells after treatment with ethanolic extract of Amomum subulatum 
indicating decrease in cell population, chromatin condensation and destruction of 
monolayer 
 
 
 
Figure 7. Flourescent Microscopic Images 
 
 
 
 
A). HeLa cells – Control, indicting viable cells stained green in colour 
 
B). HeLa cells after treatment with Ethanolic extract of Amomum subulatum 
showing dead cells stained orange in colour with loss of membrane integrity and 
cytoplasmic contents leaking out of the cell. 
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5.3  DNA Fragmentation:  
 In the control HeLa cells, there was no fragmentation observed in agarose gel. 
Fragmentation was observed in HeLa cells treated with IC50 concentration of 
standard 5 fluorouracil and ethanolic  extract of Amomum subulatum.  
 This fragmentation of DNA in ethanolic extract treated cells indicated the 
characteristics of apoptotic cells.  
 Results obtained in fragmentation studies are shown in figure 8. 
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Agarose gel electrophoresis 
1             2             3            4 
 
 
Figure 8. DNA Fragmentation in HeLa cells. 
 
DNA Fragmentation in HeLa cells.  
Lane 1: 100 base pair DNA marker  
Lane 2: HeLa cells treated with 5 Fluorouracil  
Lane 3: HeLa cells treated with ethanolic extract of Amomun subulatum  
Lane 4: HeLa cells without any treatment. 
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5.4 Real time PCR :  
The expression levels of p53, Bcl-2 were studied using RT-PCR and the results 
are shown in Figure 9 and 11. 
 
 
P53 Gene in HeLa Cell Line by gel electrophoresis 
 
                                  M       1         2          3      
 
FIGURE 9. P53 gene expression 
 
 
 
 
Figure 9: M- 100 bp DNA Ladder, Lane 1 and 2 : Samples in duplicate 
  
P53-600bp 
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Table 5.  Expression levels of p53 
P 53 
 
Relative 
Quantification 
(ng/µl) 
Standard error 
 
Control 2.25 
0.1 
 
5 fluorouracil 6.15 
0.12 
 
Ethanolic extract 3.62 
0.09 
 
          
 
 
 
Figure 10.  Graphical representation of p53 gene expression 
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BCl2 Gene in HeLa Cell Line by gel electrophoresis 
1                  2             3          M 
      
 
Figure 11: M- 100 bp DNA Ladder, Lane 1 and 2 : Samples in duplicate 
 
                                         
 
 
 
  
BCl2- 300bp 
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Table 6- Expression levels of Bcl-2                          
Bcl2 
Relative 
Quantification 
(ng/µl) 
Standard error 
 
Control 6.68 
0.106 
 
5 Fluorouracil 2.15 
0.096 
 
Ethanolic extract 3.84 
0.131 
 
 
 
 
 
Figure 12:  Graphical representation of Bcl-2 gene expression 
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6. DISCUSSION 
 
 Cancer is considered as a serious health problem worldwide. Cervical cancer is 
the third most common cancer in women. It is one of the leading cause of cancer 
mortalities in most of the countries in the world with approximately 2,88,000 deaths 
every year. 
 
  Natural phytochemicals derived from medicinal plants have attained a greater 
significance in potential management of several diseases including cancer. Several 
researches have been carried out in evaluation of plant extracts as prophylactic agents 
which offer greater potential to inhibit carcinogenic process.
[53,54]  
 
 The mechanism of inhibition of tumour progression by natural phytochemicals 
range from inhibition of genotoxic effects, increased anti inflammatory and anti oxidant 
effect, inhibition of cell proliferation, protection of intracellular communications to 
modulate apoptosis and signal transduction pathways. 
 
 Amomum subulatum  or larger cardamom is a perennial bush of the ginger 
family.
[55] 
 
 The essential oil, obtained from the steam distillation of the crushed seeds of 
Larger Cardamom, contain cineole. Cineole gives the herb its aroma as well as its 
digestive and appetizer properties. Its antioxidant properties havealso been reported. It 
has been reported to have  anti diabetic, anti fungal, anti oxidant, anti microbial, anti-
inflammatory activity. There was no previous study to prove its anti cancer activity with 
special focus to apoptosis and gene expression study in spite of presence of flavonoid 
and triterpenoid (1,8 cineole) which is considered as an agent responsible for anti cancer 
activity. So the study was carried out to evaluate the anticancer effect of ethanolic extract 
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of fruit of Amomum subulatum and the gene expression levels to determine its  role in 
cancer pathology using in vitro methods. 
 
 Dried fruits of Amomum subulatum were powdered and extracted with solvents 
like acetone, ethanol and water. Phytochemical analysis of acetone, ethanol and aqueous 
extract of Amomum subulatum showed the presence of proteins, carbohydrates, 
flavanoids, terpenoids, steroids, phenols and tannins. Cytotoxic activity was carried out 
in cervical cancer cell line HeLa with ethanolic extract and was compared with standard 
drug 5 Fluorouracil. Test for cytotoxicity was carried out by MTT assay and IC50 value 
of ethanolic extract was found to be 62.5 μg/ml. IC50 value of 5 Fluorouracil was found 
to be 7.8 μg/ml. Linearity was expressed with the help of graph plotted in Microsoft 
excel.
[55] 
 
 Apoptotic study was carried out by Microscopic analysis and DNA 
fragmentation. HeLa cells after incubation with IC50 concentration of ethanolic extract 
for 48 hours were subjected to microscopic studies. On light microscopic observation of 
ethanolic extract of Amomum subulatum treated HeLa cells, typical morphological 
features of apoptosis like destruction of monolayer, reduction of HeLa cell population, 
reduction of cell volume, loss of integrity of membrane which resulted in crooked and 
vesicle shape of the membrane and chromatin condensation were observed when 
compared to cells without any treatment. 
 
 Apoptotic effect of IC50 concentration of ethanolic extract of Amomum 
subulatum treated HeLa cells were further confirmed with the help of fluorescence 
microscopy using acridine orange and ethidium bromide. Acridine orange is a vital dye 
capable of staining both dead and live cells, where as ethidium bromide will stain only 
cells that have lost their membrane integrity. On examination of cells without any 
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treatment under fluorescent microscope, the cells were stained green in colour 
representing viable or live cells, whereas examination of cells after treatment with 
ethanolic extract showed reddish or orange colour with loss of membrane integrity and 
leakage of cytoplasmic contents representing dead cells and the obtained results were 
similar to those reported by Shahrul Hisham Zainal Ariffin et al
[50]
 in Hep G2 cells. This 
led to confirmation that ethanolic extract of Amomum subulatum showed apoptotic effect 
in cervical cancer cell line HeLa. 
 
 DNA fragmentation study was carried out by extracting DNA from the cells after 
treatment with IC50 concentration of ethanolic extract of Amomum subulatum and 
standard 5 Fluorouracil for 48 hours and also from cells without any treatment. DNA 
agarose gel electrophoresis showed cleavage of chromosomal DNA into 
oligonucleosomal fragments in HeLa cells treated Ethanolic extract of Amomum 
subulatum and 5 fluorouracil, there was no fragmentation seen in control. This shows 
that Ethanolic extract of Amomum subulatum has anticancer activity. The results 
obtained were similar to the results shown by Abhimanyu kumar Jha et al
[51]
 using SiHa 
cell line. This fragmentation of DNA indicated the characteristics of apoptotic cells. 
Thus ethanolic extract of Amomum subulatum causes DNA damage in HeLa cells, 
thereby inducing apoptosis. 
 
 Cancer DNA markers like p53, Bcl2,  plays a major role in cancer pathology and 
their expression levels determine the progression of the disease. The expression levels of 
p53 and Bcl2 were studied in cells treated with IC50 concentration of ethanolic extract of 
Amomum subulatum and 5 Fluorouracil by RT-PCR methodology using SYBR green. 
 
 The expression levels of p53 was found to be increased in cells treated with 
ethanolic extract of Amomum subulatum and in cells treated with 5 Fluorouracil when 
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compared to cells without any treatment, indicating the ability of ethanolic extract to up 
regulate p53 and promote apoptosis. The results obtained was similar to those obtained 
by Azizi et al.
[49] 
 
 Bcl-2 and its family of proteins play a significant role in regulation of Apoptosis. 
Bcl-2 plays a major role in cancer and its resistance thereby interfering with therapeutic 
action of chemotherapeutic drugs. High expression of anti-apoptotic members like Bcl-2 
found in human cancers leads to neoplastic cell expansion by interfering with normal cell 
death mechanism. Decrease in expression of Bcl-2 leads to apoptosis. In this study, the 
expression levels of Bcl-2 in ethanolic extract treated cells and 5 Fluorouracil treated 
cells was found to be decreased when compared to expression in cells without any 
treatment which implies that apoptosis in HeLa cancerous cells may be due to decreased 
expression of Bcl-2. The results obtained were similar to those reported by Gul Ozcan 
Arican et al
[39]
 in Hela cells. 
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7. CONCLUSION 
 Phytochemical analysis of acetone, ethanol and aqueous extracts of Amomum 
subulatum revealed the presence of proteins, terpenoids, tannins, steroids, phenols 
and flavonoids.  
 In this study, ethanolic extract of Amomum subulatum  showed cytotoxic activity in 
cervical cancer cell line HeLa by MTT assay. 
 The Apoptotic effect was confirmed by loss of membrane integrity, chromatin 
condensation, leakage of cytoplasmic contents and fragmentation of DNA by 
microscopic methods.  
 Its apoptotic and anti cancer effect may be due to up regulation of genes like p53 and 
down regulation of gene Bcl-2, which was confirmed by RT-PCR.  
 The ethanolic extract of Amomum subulatum possess anti cancer effect and for future 
perspective, it can be further confirmed by isolating the compounds responsible for 
the activity and studying the exact mechanism by which the plant possess this 
activity and confirm the results using in vivo animal models.  
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8.  LIST OF ABBREVATIONS 
 
5-FU   5-Fluorouracil 
ALL   Acute Lymphocytic Leukemia 
Bax   Bcl-2 associated X protein 
Bcl-2   B-cell lymphoma 2 
BMI   Body Mass Index 
bp   base pairs 
BRCA1  Breast cancer susceptibility protein 
cDNA   Complementary DNA 
CIN   Cervical intraepithelial neoplasia 
CLL   Chronic Lymphocytic Leukemia 
DBD   DNA Binding Domain 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribo Nucleic Acid 
dNTP   Deoxynucleotide Triphosphate 
DTT   Dithiothreitol 
ELISA   Enzyme-linked immunosorbent assay 
FBS   Foetal bovine serum 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
HeLa   Henrietta Lacks 
Hgb   Hemoglobin 
HPV   Human Papilloma Virus 
IC50   Median inhibition concentration 
IFN-γ   Interferon Gamma 
IL   Interleukin 
INCTR  International network for cancer treatment and research 
JNK   c-Jun N-terminal kinases 
KDa   kilo Dalton 
LED   Light-emitting diode 
MAPK   Mitogen-Activated protein kinases 
MCF-7  Michigan Cancer Foundation-7 
Mdm2   Mouse double minute 2 homolog 
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MEM   Minimum Essential Medium 
CHOP  Chemotherapy regimen used in the treatment of non-Hodgkin 
 lymphoma 
MTT  Dimethyl thiazolyl diphenyl tetrazolium salt 
MuLV  Murine Leukemia virus 
NaOH  Sodium Hydroxide 
NF-κB  Nuclear Factor Kappa-Light-Chain-Enhancer Of Activated B cells 
NK  Natural Killer cells 
OD  Optical density 
p53  Protein 53 
PBS  Phosphate Buffer Saline 
PCR  Polymerase chain reaction 
qPCR  quantitative or real time Polymerase chain reaction 
RBC  Red Blood Cells 
RNA  Ribo Nucleic Acid 
rpm  revolutions per minute 
RT-PCR  Reverse transcriptase Polymerase chain reaction 
SDS  sodium dodecyl sulphate 
SiRNA  Small interfering RNA 
SYBR  Synergy Brands, Inc. 
TAE  Tris-acetate EDTA 
Th1  T helper cells 1 
TLC  Thin layer chromatography 
TNF  Tumor Necrosis Factor 
TNFR  Tumor Necrosis Factor Receptor 
TP53  Tumor Protein 53 
TPVG  Trypsin, PBS, Versene/EDTA, Glucose 
VEGF  Vascular endothelial growth factor 
WBC  White Blood Cells 
WHO  World Health Organisation 
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